Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

US Pharmaceuticals Ishares ETF (IHE)

US Pharmaceuticals Ishares ETF (IHE)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Should You Invest in the VanEck Vectors Pharmaceutical ETF (PPH)?

Sector ETF report for PPH

PPH : 52.62 (-0.64%)
JNJ : 134.17 (+0.77%)
NVO : 59.84 (+0.89%)
PFE : 33.64 (+2.34%)
PJP : 54.37 (-0.64%)
IHE : 132.61 (-0.66%)
Pharma ETFs Gain on Healthy Q4 Earnings

Strong results led to solid trading in pharma ETFs over the past week.

PPH : 52.62 (-0.64%)
PJP : 54.37 (-0.64%)
XPH : 34.81 (-0.77%)
IHE : 132.61 (-0.66%)
FTXH : 19.12 (-0.73%)
4 Sector ETFs Sizzling With Solid Buybacks

Inside the sectors that have seen strong share buybacks in the past 10 years.

WFC : 26.23 (-3.64%)
JPM : 84.05 (-3.95%)
C : 37.49 (-4.44%)
BAC : 20.03 (-2.63%)
AAP : 84.65 (-4.25%)
ORCL : 49.40 (-0.80%)
MSFT : 153.83 (-0.92%)
MS : 33.85 (-0.15%)
IHE : 132.61 (-0.66%)
XLF : 19.64 (-2.00%)
MCD : 160.33 (-0.72%)
SBUX : 63.05 (-3.00%)
INTC : 54.13 (-0.40%)
V : 151.85 (-3.52%)
MA : 237.03 (-0.77%)
4 Sector ETFs Sizzling With Solid Buybacks

Inside the sectors that have seen strong share buybacks in the past 10 years.

JPM : 84.05 (-3.95%)
WFC : 26.23 (-3.64%)
C : 37.49 (-4.44%)
BAC : 20.03 (-2.63%)
AAP : 84.65 (-4.25%)
ORCL : 49.40 (-0.80%)
MSFT : 153.83 (-0.92%)
SLI : 39.99 (+0.05%)
MS : 33.85 (-0.15%)
IHE : 132.61 (-0.66%)
XLY : 92.41 (-1.74%)
XLF : 19.64 (-2.00%)
MCD : 160.33 (-0.72%)
SBUX : 63.05 (-3.00%)
INTC : 54.13 (-0.40%)
V : 151.85 (-3.52%)
M : 4.81 (+8.09%)
Should You Invest in the VanEck Vectors Pharmaceutical ETF (PPH)?

Sector ETF report for PPH

PPH : 52.62 (-0.64%)
NVO : 59.84 (+0.89%)
ABBV : 73.37 (-2.34%)
BMY : 55.53 (+0.58%)
PJP : 54.37 (-0.64%)
IHE : 132.61 (-0.66%)
Pharma ETFs Set to Benefit Post Strong Q3 Earnings

Robust results led to solid trading in pharma ETFs in a month.

XPH : 34.81 (-0.77%)
PJP : 54.37 (-0.64%)
PPH : 52.62 (-0.64%)
IHE : 132.61 (-0.66%)
FTXH : 19.12 (-0.73%)
JNJ Beats, Ups View: Healthcare ETFs to Buy

Johnson & Johnson continued its long streak of earnings beat and outpaced revenue estimates. It also raised its guidance for the full year.

JNJ : 134.17 (+0.77%)
XLV : 86.78 (-0.90%)
IYH : 183.51 (-1.02%)
IHE : 132.61 (-0.66%)
VHT : 162.13 (-1.12%)
IEIH : 25.15 (-0.72%)
Pharma Q2 Earnings Growth Highest: Time to Buy ETFs?

Despite robust results, pharma ETFs have been trending downward in a month.

PJP : 54.37 (-0.64%)
XPH : 34.81 (-0.77%)
PPH : 52.62 (-0.64%)
IHE : 132.61 (-0.66%)
FTXH : 19.12 (-0.73%)
Healthcare ETFs in Focus on JNJ's Q2 Earnings Beat

Johnson & Johnson beat the second-quarter earnings and revenue estimates but warned on competition from generics and biosimilars that could impact its third-quarter results.

JNJ : 134.17 (+0.77%)
IHE : 132.61 (-0.66%)
XLV : 86.78 (-0.90%)
IYH : 183.51 (-1.02%)
VHT : 162.13 (-1.12%)
IEIH : 25.15 (-0.72%)
AbbVie to Buy Allergan: Prescribed ETFs

AbbVie has agreed to buy Botox-maker Allergan for $63 billion in a cash-and-stock deal. The news has put the spotlight on a number of healthcare ETFs.

BMY : 55.53 (+0.58%)
AGN : 175.71 (-1.03%)
ABBV : 73.37 (-2.34%)
BBH : 128.32 (-0.77%)
PPH : 52.62 (-0.64%)
XPH : 34.81 (-0.77%)
IHE : 132.61 (-0.66%)
PJP : 54.37 (-0.64%)
CELG : 108.24 (+0.10%)
Pharma ETFs Down Despite Solid Q1 Results

Despite such robust results, pharma ETFs have been trending downward in a month.

XPH : 34.81 (-0.77%)
PJP : 54.37 (-0.64%)
IHE : 132.61 (-0.66%)
PPH : 52.62 (-0.64%)
FTXH : 19.12 (-0.73%)
Pharma ETFs Down Despite Solid Q1 Results

Despite such robust results, pharma ETFs have been trending downward in a month.

XPH : 34.81 (-0.77%)
PJP : 54.37 (-0.64%)
IHE : 132.61 (-0.66%)
PPH : 52.62 (-0.64%)
FTXH : 19.12 (-0.73%)
JNJ Beats, Ups Sales Growth View: Healthcare ETFs in Focus

Johnson & Johnson continued its long streak of earnings beat and also outpaced revenue estimates. Though it raised the guidance for full-year sales growth, it tightened the earnings per share forecast....

XLV : 86.78 (-0.90%)
VHT : 162.13 (-1.12%)
IHE : 132.61 (-0.66%)
IYH : 183.51 (-1.02%)
IEIH : 25.15 (-0.72%)
JNJ Beats, Ups Sales Growth View: Healthcare ETFs in Focus

Johnson & Johnson continued its long streak of earnings beat and also outpaced revenue estimates. Though it raised the guidance for full-year sales growth, it tightened the earnings per share forecast....

XLV : 86.78 (-0.90%)
VHT : 162.13 (-1.12%)
IHE : 132.61 (-0.66%)
IYH : 183.51 (-1.02%)
IEIH : 25.15 (-0.72%)
Why These Pharma ETFs Rallied on Thursday

A few pharma ETFs hit a one-month high on Feb 28. Why?

XPH : 34.81 (-0.77%)
IHE : 132.61 (-0.66%)
PJP : 54.37 (-0.64%)
TGTX : 8.95 (-5.09%)
HZNP : 31.37 (-1.51%)
RKDA : 2.75 (-1.43%)
FTXH : 19.12 (-0.73%)
Why These Pharma ETFs Rallied on Thursday

A few pharma ETFs hit a one-month high on Feb 28. Why?

XPH : 34.81 (-0.77%)
IHE : 132.61 (-0.66%)
PJP : 54.37 (-0.64%)
TGTX : 8.95 (-5.09%)
HZNP : 31.37 (-1.51%)
RKDA : 2.75 (-1.43%)
FTXH : 19.12 (-0.73%)
A Look at Pharma ETFs Post Q4 Results

The strong results but downbeat guidance led to decent returns in the pharma ETFs over the past month.

IHE : 132.61 (-0.66%)
PPH : 52.62 (-0.64%)
PJP : 54.37 (-0.64%)
XPH : 34.81 (-0.77%)
FTXH : 19.12 (-0.73%)
A Look at Pharma ETFs Post Q4 Results

The strong results but downbeat guidance led to decent returns in the pharma ETFs over the past month.

IHE : 132.61 (-0.66%)
PPH : 52.62 (-0.64%)
PJP : 54.37 (-0.64%)
XPH : 34.81 (-0.77%)
FTXH : 19.12 (-0.73%)
Should You Invest in the VanEck Vectors Pharmaceutical ETF (PPH)?

Sector ETF report for PPH

PPH : 52.62 (-0.64%)
GSK : 37.14 (-1.49%)
LLY : 139.66 (-1.77%)
NVO : 59.84 (+0.89%)
PJP : 54.37 (-0.64%)
IHE : 132.61 (-0.66%)
JNJ Beats, Offers Bleak Outlook: Health Care ETFs in Focus

Johnson & Johnson expects its sales growth to slow down this year due to pricing pressures and generic-drug competition for its pharmaceutical division. This has put healthcare ETFs in focus.

JNJ : 134.17 (+0.77%)
XLV : 86.78 (-0.90%)
IHE : 132.61 (-0.66%)
VHT : 162.13 (-1.12%)
IYH : 183.51 (-1.02%)
IEIH : 25.15 (-0.72%)

Van Meerten Stock Picks

My 5 Favorite Mid Caps
Summary 100% technical buy signals with current momentum.
CRUS -2.23 , SEDG -2.49 , THC -1.30 , TER -0.57 , LITE -3.30
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

InsideFutures Commentary

InsideFutures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar